Since 2018, imaging fibroblast activation protein (FAP) expression in tumor microenvironment utilizing fibroblast activation protein inhibitors (FAPi) labeled with gallium-68 has gained interest and an increasing number of studies have attempted to explore this modality in various cancers. Here, FAP is linked to neoplasm.